But the recent fda approval of a promising medication is the latest in a long line of treatments from johnson & johnson that are helping patients with ibd Income statements, balance sheets, cash flow statements and key ratios. Therefore, it is no surprise that j&j is one of the top three pharmaceutical companies based on its r&d spending
Erothots
Johnson & johnson also has one of the largest current research and.
Johnson & johnson annual research and development expenses for 2023 were $15.085b, a 6.72% increase from 2022
Johnson & johnson annual research and development expenses for 2022 were $14.135b, a 0.99% decline from 2021. Johnson & johnson does not currently have any hardcopy reports on annualreports.com Click the button below to request a report when hardcopies become available. Ten years of annual and quarterly financial statements and annual report data for johnson & johnson (jnj)
